Resumo

RUBIO RUIZ, Sebastián Patricio  e  AREVALO PELAEZ, Carlos Eduardo. Influence of obesity on the severity of SARS-CoV-2 infection. Rev. virtual Soc. Parag. Med. Int. [online]. 2023, vol.10, n.1, pp.98-106. ISSN 2312-3893.  https://doi.org/10.18004/rvspmi/2312-3893/2023.10.01.98.

Obesity is a chronic metabolic disease associated with increased morbidity and mortality whose prevalence has increased to pandemic levels, making it a typical clinical risk factor for worse prognosis in patients with COVID-19. The purpose of this review was to categorize the main pathophysiological factors that influence the severity of COVID-19 in patients with obesity, through a systematic search for articles published up to March 11, 2022 using different databases (Scopus, Cochrane, PubMed, Web of Science and Medline).

The results indicate that the presence of angiotensin II allows the SARS-CoV-2 virus to enter the adipose tissue cells, making it an important reservoir for the virus, which causes faster dissemination to neighboring organs. These increased values of angiotensin II in the lung can induce vasoconstriction which in turn leads to ventilation/perfusion mismatch and hypoxemia, as well as inflammation and oxidative damage. The increase in angiotensin II in the obese can exacerbate the increase in the level of angiotensin II induced by COVID-19, leading to more severe lung injury, in addition to the formation of microclots that collapse the irrigation at the capillary level, especially in the alveolus, causing failure at this level with fluid extravasation and fulminant pneumonia. In addition, obesity produces an alteration of the immune system, thus compromising its ability to respond to respiratory infection and leading to a worsening of the disease.

Palavras-chave : obesity; COVID 19; angiotensin II; respiratory tract infections.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )